Intuitive Surgical’s Recurring Revenue Model Drives Long-Term Value

Intuitive Surgical (ISRG) continues to dominate the robotic surgery market, but the company's valuation is driven by more than just hardware sales. While the placement of da Vinci systems is a key growth driver, the firm's primary financial engine is a powerful flywheel of recurring revenue generated after the initial sale. The company employs a strategic model where the installation of a robot creates a permanent stream of income through necessary instruments, accessories, and maintenance services. This structure transforms one-time capital expenditures by hospitals into long-term annuity-like revenue for the company. Recent data highlights the strength of this trend. In the first quarter of 2026, Intuitive Surgical placed 431 da Vinci systems, increasing its total global installed base to 11,395 units—a 12% year-over-year increase. More significantly, the volume of surgeries performed using these robots rose 17% over the same period, indicating higher utilization per system. Financial breakdowns reveal that only 23% of the company's total revenue comes from the sale of the robots themselves. The vast majority of the top line is powered by instruments and accessories, which account for 60% of revenue, and services, which contribute approximately 15%. Despite a lofty price-to-earnings ratio of 58x, which may appeal primarily to aggressive growth investors, the scalability of this recurring revenue model provides a fundamental cushion. As the installed base grows and the variety of compatible surgeries expands, the company's capacity for cash generation increases proportionally.